ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1462

Pathogenesis of Vaginal Dryness in Primary Sjögren’s Syndrome: A Histopathological Case-control Study

Jolien van Nimwegen1, Karin van der Tuuk 1, Sylvia Liefers 1, Gwenny Verstappen 1, Robin Wijnsma 1, Harry Hollema 1, Marian Mourits 1, Hendrika Bootsma 2 and Frans Kroese 1, 1University Medical Center Groningen, University of Groningen, Groningen, Netherlands, 2University of Groningen, Groningen, Netherlands

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Sexuality, Sjogren's syndrome, Vaginal dryness, vasculogenesis and mucosal T cells

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: Sjögrenʼs Syndrome – Basic & Clinical Science Poster II

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Women with primary Sjögren’s syndrome (pSS) often experience vaginal dryness, but the pathogenesis of this symptom is unknown. Previously, we reported impaired vaginal health and presence of a subepithelial infiltrate in the vagina of women with pSS1. In the current analysis, we quantitatively studied changes in lymphocyte subsets, endothelial cells and soluble immune markers in the vagina and endocervix of women with pSS, compared to age-matched controls, which may explain vaginal dryness.

Methods: Gynaecological examinations were performed in 10 premenopausal women with pSS, fulfilling the ACR-EULAR criteria, with symptoms of vaginal dryness, and 10 premenopausal non-pSS controls scheduled for laparoscopic procedures. Participants with inflammatory or infectious gynaecological morbidity were excluded. Endocervical swab and cervicovaginal lavage samples were collected, in which levels of pro-inflammatory chemokines and cytokines were analyzed using a multiplex bead based immunoassay. Mid-vaginal biopsies and endocervical biopsies were collected and stained for leucocyte markers, caldesmon for smooth muscle cells, ERG for endothelial cells and anti-podoplanin (clone D2-40) for lymphatic endothelium. The number of positive pixels/µm2 was calculated digitally using Aperio ImageScope v 12.1.

Results: One pSS patient was excluded due to chlamydia, and 2 controls due to discovery of endometriosis during their laparoscopy. In the remaining 9 patients and 8 controls, median age was 36 years (IQR 33-46) and 41 years (36-44), respectively (p=0.61). A higher level of CXCL10 was measured in endocervical swabs of pSS patients (median 37.1 pg/ml, IQR 19.4-66.1) compared to controls (median 12.6 pg/ml, IQR 5.9-31.1, p= 0.046). No differences were found in levels of APRIL, BAFF, RANKL, TNF-α, CCL2, CXCL11, CXCL13, IL6, IL7 or IL8. One vaginal biopsy from a control was excluded from analysis as it was too superficial, consisting for 98% of epithelium. Three pSS and two control cervix biopsies which did not show representative endocervical tissue were excluded from analysis. The number of CD45+ and CD3+ cells (expressed as number of positive pixels/µm2) in vaginal biopsies was significantly higher in pSS patients (p=0.012 for CD45, p=0.008 for CD3). Lymphocytic infiltration was mainly located in the subepithelial layer, with aggregates in dermal papillae. Endocervical CD45+ leucocytic infiltrates were seen in patients as well as controls, but CD20+ positive pixels/µm2 were significantly higher in pSS patients (p=0.041). Importantly, there was a significantly lower number of vascular smooth muscle cells (caldesmon+ pixels/µm2) in the vagina of pSS (p=0.031). In the endocervix, no significant differences were seen in endothelial or smooth muscle cells.

Conclusion: Our findings indicate that in addition to chronic inflammation, vascular disturbances in the vaginal mucosa are likely to contribute to vaginal dryness in women with pSS.

Reference: 1JF Van Nimwegen et al. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/subepithelial-infiltrate-of-the-vagina-in-primary-sjogrens-syndrome-the-cause-of-vaginal-dryness/.


Disclosure: J. van Nimwegen, Bristol-Myers Squibb, 5, 8; K. van der Tuuk, None; S. Liefers, None; G. Verstappen, None; R. Wijnsma, None; H. Hollema, None; M. Mourits, None; H. Bootsma, Bristol-Myers Squibb, 2, 5, 8, GlaxoSmithKline, 2, 5, HarmonicSS, 2, MedImmune, 2, 5, Medimmune, 5, Novartis, 5, 8, Roche, 2, 5, UCB, 2, 5, Union Chimique Belge, 5; F. Kroese, Bristol-Myers Squibb, 2, 5, 8, Janssen-Cilag, 8, Roche, 8.

To cite this abstract in AMA style:

van Nimwegen J, van der Tuuk K, Liefers S, Verstappen G, Wijnsma R, Hollema H, Mourits M, Bootsma H, Kroese F. Pathogenesis of Vaginal Dryness in Primary Sjögren’s Syndrome: A Histopathological Case-control Study [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/pathogenesis-of-vaginal-dryness-in-primary-sjogrens-syndrome-a-histopathological-case-control-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pathogenesis-of-vaginal-dryness-in-primary-sjogrens-syndrome-a-histopathological-case-control-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology